Valuation: ResMed Inc.

Market Cap 31.78B 159B 28.4B 26.49B 24.06B 45.32B 3,074B 45.66B 318B 124B 1,564B 119B 117B 5,026B P/E 2027 *
19.4x
P/E 2028 * 17.7x
Enterprise Value 30.83B 154B 27.54B 25.7B 23.34B 43.96B 2,982B 44.29B 309B 121B 1,517B 116B 113B 4,876B EV / Sales 2027 *
5.31x
EV / Sales 2028 * 4.89x
Free-Float
74.65%
Yield 2027 *
1.18%
Yield 2028 * 1.3%
1 day-0.67%
3 months-0.67%
6 months-15.84%
Current year-27.07%
Current year 243.27
Extreme 243.27
357.02
1 year 243.27
Extreme 243.27
376.78
3 years 187.67
Extreme 187.67
397
5 years 183.79
Extreme 183.79
397
10 years 144.25
Extreme 144.25
397
Manager TitleAgeSince
Chief Executive Officer 53 2013-02-28
Director of Finance/CFO 40 2026-05-03
Chief Tech/Sci/R&D Officer - 2024-01-31
Director TitleAgeSince
Director/Board Member 78 2004-12-31
Chairman 53 2023-01-24
Chairman 83 1989-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-.--% - - 31.78B
+0.83%-1.92%+22.79%+32.80% 245B
+1.34%-1.38%+4.66%+0.58% 154B
+2.41%+1.94%-5.99%+40.19% 146B
-1.45%-4.74%-56.64%-20.22% 60.26B
-0.81%-0.63%+11.81%+16.39% 49.44B
-0.14%-1.87%+22.03%+52.83% 47.67B
-1.23%+1.44%-21.41%-18.80% 48.04B
-0.35%-1.03%-7.75%+34.78% 45.74B
-0.10%-0.77%+36.95%+63.05% 42.84B
Average -0.01%-1.73%+0.72%+22.40% 93.2B
Weighted average by Cap. +0.61%-2.10%+4.58%+23.25%

Financials

2027 *2028 *
Net sales 5.8B 29.03B 5.19B 4.84B 4.39B 8.28B 561B 8.34B 58.14B 22.72B 286B 21.79B 21.32B 918B 6.17B 30.87B 5.51B 5.14B 4.67B 8.8B 597B 8.87B 61.82B 24.15B 304B 23.17B 22.67B 976B
Net income 1.64B 8.21B 1.47B 1.37B 1.24B 2.34B 159B 2.36B 16.44B 6.42B 80.74B 6.16B 6.03B 260B 1.78B 8.91B 1.59B 1.48B 1.35B 2.54B 172B 2.56B 17.84B 6.97B 87.64B 6.69B 6.54B 282B
Net Debt -954M -4.77B -852M -795M -722M -1.36B -92.25B -1.37B -9.55B -3.73B -46.91B -3.58B -3.5B -151B -1.61B -8.05B -1.44B -1.34B -1.22B -2.3B -156B -2.31B -16.13B -6.3B -79.21B -6.04B -5.91B -255B
Projected Income Statement - Annual - ResMed Inc.
Logo ResMed Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.2%); - masks (36.9%); - software as a service (11.9%): residential care management software solutions. At the end of June 2026, the group had 9 production sites located in the United States (4), Australia, China, Singapore, Malaysia and France. The United States accounts for 63% of net sales.
Employees
11,370
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - ResMed Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
225.98USD
Average target price
250.22USD
Spread / Average Target
+10.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ResMed Inc.